MUMBAI:
Hetero
announced that its European subsidiary Amarox has acquired Tarbis Farma, a company operating in
Spain
, from Grupo Ferrer Internacional. Tarbis Farma comes with a robust product portfolio and an extensive marketing network with well-experienced personnel in retail business across Spain, says a company statement.
The acquisition enables Hetero with a strong front-end marketing presence giving Amarox the required commercial
infrastructure
, product portfolio, manpower and a seamless entry into the retail, hospital and tender business channels in Spain.
AV Narasa Reddy, executive director of Hetero Labs, stated that this acquisition fits very well with Hetero’s growth strategy in EU giving Amarox a platform to reach out to the customers in a robust way with the present portfolio and Hetero’s pipeline of products.
Ready to Master Stock Valuation? ET’s Workshop is just around the corner!
A business journalist with around two decades of experience track...
Read MoreA business journalist with around two decades of experience tracking key consumer-focussed sectors like consumer durables, retail, consumer goods, aviation, automobiles and advertising, as well as economic ministries of the Union government. Now, writes primarily on pharmaceuticals and healthcare, and on issues of consumer interest. Besides also looks at trends that are shaping consumer behaviour and the broad consumer landscape. \nYou can follow Rupali on Twitter@Rupalijee.
Read Less
Start a Conversation
Post comment